Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

NCT06529744 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT06529744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06529744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Recruiting
Start date
November 11, 2023
Completion date
November 30, 2027
Enrollment
500 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, corticobasal syndrome, dementia, dementia with lewy bodies, frontotemporal dementia, mild cognitive impairment, parkinson disease, primary progressive aphasia, progressive supranuclear palsy, vascular dementia